2019 ASCO GU Symposium

2019 ASCO GU Symposium

INTERVIEW WITH ANDREA APOLO
Immune Checkpoint Inhibitors Trials in Urothelial Cancer: Recent Updates and Future Outlook

VIEW ALL BLADDER CANCER VIDEOS

2019 ASCO GU Symposium

2019 ASCO GU Symposium

INTERVIEW WITH TOM KEANE
A Look at Established Paradigms in Androgen Deprivation Therapy in the Treatment of Advanced Prostate Cancer

VIEW ALL ADV PROSTATE VIDEOS

2019 ASCO GU Symposium

2019 ASCO GU Symposium

INTERVIEW WITH JEREMIE CALAIS
Molecular Imaging for Prostate Cancer Salvage Radiotherapy Planning

VIEW ALL IMAGING VIDEOS

2019 ASCO GU Symposium

2019 ASCO GU Symposium

INTERVIEW WITH FRED SAAD
Delaying Disease Progression in Early Nonmetastatic CRPC Treatment

VIEW ALL nmCRPC VIDEOS

Featured Videos

EAU 2014 - Poster: Consistent long-term efficacy and safety of onabotulinumtoxinA in patients with neurogenic detrusor overactivity: Final results of repeated treatments up to 4 years

STOCKHOLM, SWEDEN (UroToday.com) - Presented by Gilles Karsenty,1 Heinrich Schulte-Baukloh,2 Roger Dmochowski,3 Karen Ethans,4 Brenda Jenkins,5 Steven Guard,6 Ho-Jin Lee,7 Michael Kennelly8 at the 29th Annual European Association of Urology (EAU) Congress - April 11 - 15, 2014 - Stockholmsmässan - Stockholm, Sweden.

Poster-693 EAU thumb

1Aix-Marseille Université, Marseille, France; 2St. Hedwig-Krankenhaus, Berlin, Germany; 3Vanderbilt University Medical Center, Nashville, TN, USA; 4University of Manitoba, Winnipeg, Canada; 5Allergan, Inc., Irvine, CA, USA; 6Allergan, Ltd., Marlow, UK; 7Allergan, Inc., Bridgewater, NJ, USA; 8Carolinas Medical Center, Charlotte, NC, USA

 

Conference Coverage
 
Recent data from conferences worldwide
Journals
Publications focusing on urologic cancer treatments through original manuscripts
Everyday Urology Volume 4 Issue 1

Everyday Urology™ - Oncology Insights

PCAN cover

Prostate Cancer and Prostatic Diseases

From the Editor

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe